论文部分内容阅读
目的:分析滋养细胞肿瘤的规范化治疗及效果。方法:对1990～2008年收治的180例滋养细胞肿瘤患者的临床资料进行回顾性分析。结果:180例滋养细胞肿瘤患者平均年龄为31.8岁,126例患者行单纯化疗,54例患者行化疗加手术治疗。75例绒毛膜上皮癌的治愈率是79.45%,105例侵蚀性葡萄胎的治愈率是90.47%。结论:滋养细胞肿瘤患者首次化疗规范、足量并坚持巩固化疗,合理选择手术时机是影响滋养细胞肿瘤预后的重要因素。
Objective: To analyze the normalized treatment and effect of trophoblastic tumor. Methods: The clinical data of 180 cases of trophoblastic tumor admitted from 1990 to 2008 were analyzed retrospectively. Results: The average age of 180 patients with trophoblastic tumor was 31.8 years. 126 patients underwent simple chemotherapy and 54 patients received chemotherapy and surgery. The cure rate of 75 cases of choriocarcinoma was 79.45%, and the cure rate of 105 cases of invasive mole was 90.47%. CONCLUSION: The first chemotherapy regimen in patients with trophoblastic tumors, enough and adhere to consolidation chemotherapy, a reasonable choice of timing of surgery is an important factor affecting the prognosis of trophoblastic tumors.